4-Bromo-2-ethyl-1-iodobenzene

Catalog No.: 
ACBQFY638
CAS No.: 
175278-30-5
Molecular Formula: 
C8H8BrI
Molecular Weight: 
310.96
4-Bromo-2-ethyl-1-iodobenzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$62.00In stockIn stock
100g98%$193.00In stockIn stock
500g98%$946.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-2-ethyl-1-iodobenzene
IUPAC Name4-bromo-2-ethyl-1-iodobenzene
MDL No.MFCD00221458
Molecular FormulaC8H8BrI
Molecular Weight310.96
SMILESIC1=CC=C(Br)C=C1CC
InChI KeyJWKQXPHYKRQLEJ-UHFFFAOYSA-N
SynonymMFCD00221458 | FS-4168 | 1-iodo-2-ethyl-4-bromobenzene | JWKQXPHYKRQLEJ-UHFFFAOYSA-N | A812053 | Benzene, 4-bromo-2-ethyl-1-iodo- | FT-0643699 | 4-bromo-2-ethyl-1-iodobenzene | 4-bromo-2-ethyl-1-iodo-benzene | SY021073 | DTXSID20375742 | AKOS015890181 | 4
CAS No.175278-30-5
PubChem CID2761396

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBQFY638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHVYO791 route compound structure diagram
    ACHVYO79130273-22-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBQFY638 route product structure diagram
    ACBQFY638175278-30-5In Stock
Inquiry

2. ACBQFY638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEYFW036 route compound structure diagram
    ACEYFW0361261648-81-0In Stock
  2. Then
  3. ACBQFY638 route product structure diagram
    ACBQFY638175278-30-5In Stock
Inquiry

3. ACBQFY638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBQFY638 route product structure diagram
    ACBQFY638175278-30-5In Stock
Inquiry

Comments (0)